AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.
Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the House for its passage yesterday of H.R. 2430, the Food and Drug Administration Reauthorization Act (FDARA) of 2017. H.R. 2430 reauthorizes FDA’s critical user fee programs.
Press Release: The U.S. House Energy and Commerce Committee’s Subcommittee on Health held a hearing today on the “Pharmaceutical Information Exchange (PIE) Act of 2017” (H.R. 2026).